Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer.

Bader Alshamsan Ahmed Mostafa Gad Maaz Kamal Alata Mashari Jemaan Alzahrani Tusneem Elhassan Jean Paul Atallah

Published in: Journal of oncology (2022)

Capecitabine monotherapy is effective and well-tolerated as a palliative treatment for R/M NPC. Despite the lower incidence of HFS in our patients, it remained a favorable prognostic factor for objective response and progression-free survival.

Keyphrases

prognostic factors
combination therapy
free survival
end stage renal disease
palliative care
squamous cell carcinoma
small cell lung cancer
chronic kidney disease
open label
randomized controlled trial
phase ii study
radiation therapy
phase iii
metastatic breast cancer
young adults
double blind